ABSTRACT

Coronary artery disease is the most common cause of morbidity and mortality in industrialized countries. Despite many advances made in cardiovascular medicine in recent years, a significant number of patients are not optimal candidates for surgical revascularization or interventional procedures. The promotion of new vessel growth may be one of the most promising methods in the treatment of these patients with non-operable coronary artery disease.